Zydus Lifesciences Q1 PAT may dip 10.6% YoY to Rs 505.2 cr: Prabhudas Lilladher

Prabhudas Lilladher has come out with its first quarter (April-June’ 22) earnings estimates for the Healthcare sector. The brokerage house expects Zydus Lifesciences to report net profit at Rs 505.2 crore down 10.6% year-on-year (up 22.5% quarter-on-quarter).

Net Sales are expected to decrease by 1.8 percent Y-o-Y (up 2.3 percent Q-o-Q) to Rs 3,953.9 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 11.5 percent Y-o-Y (up 15 percent Q-o-Q) to Rs 825.6 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.